SCHEMBL17099460

SCHEMBL17099460

CC(C)(C)N(C(=O)O)c1cc([N+](=O)[O-])ccc1Br

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
HTT P42858 2/20 0.42
TP53 P04637 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 4/20 0.38
CYP3A4 P08684 2/20 0.38
ALOX15 P16050 1/20 0.38
GAA P10253 2/20 0.38
THRB P10828 1/20 0.38
KMT2A Q03164 2/20 0.37
TSHR P16473 1/20 0.37
CYP1A2 P05177 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
NPY1R P25929 1/20 0.36
NPY2R P49146 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16735812 1.00 ALDH1A1 (0.44) ALDH1A1HTTTP53L3MBTL1MAPT
SCHEMBL18053692 0.85 ALDH1A1 (0.40) ALDH1A1HTTTP53L3MBTL1MAPT
SCHEMBL1028886 0.84 L3MBTL1 (0.49) ALDH1A1HTTTP53L3MBTL1MAPT
SCHEMBL1028889 0.84 L3MBTL1 (0.49) ALDH1A1HTTTP53L3MBTL1MAPT
SCHEMBL3509381 0.83 ALDH1A1 (0.46) ALDH1A1HTTTP53L3MBTL1MAPT
SCHEMBL3509375 0.83 ALDH1A1 (0.46) ALDH1A1HTTTP53L3MBTL1MAPT
SCHEMBL2209281 0.81 ALDH1A1 (0.56) ALDH1A1HTTL3MBTL1MAPTTDP1
SCHEMBL2209277 0.81 ALDH1A1 (0.56) ALDH1A1HTTL3MBTL1MAPTTDP1
SCHEMBL1026260 0.80 ALDH1A1 (0.48) ALDH1A1HTTTP53L3MBTL1MAPT
SCHEMBL1026262 0.80 ALDH1A1 (0.48) ALDH1A1HTTTP53L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015143376-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS NIVALIS THERAPEUTICS, INC. (US) 2015-09-24 WO disclosed